Harm reduction and treatment programmes are essential for reducing harms for people who inject drugs (PWID). We aimed to update estimates from a 2017 review of global coverage of needle and syringe exchange programmes (NSPs), opioid agonist treatment (OAT), and other harm reduction services that target PWID (eg, take-home naloxone [THN] programmes, supervised consumption facilities, and drug checking services).
Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review
Academic article
Source : The Lancet Global Health
Published: 2023